CyberKnife with Tumor Tracking: An Effective Treatment for High-Risk Surgical Patients with Stage I Non-Small Cell Lung Cancer

CyberKnife with Tumor Tracking: An Effective Treatment for High-Risk Surgical Patients with Stage I Non-Small Cell Lung Cancer

Published data suggests that wedge resection for stage I non-small cell lung cancer (NSCLC) is associated with improved overall survival compared to stereotactic body radiation therapy. We report CyberKnife outcomes for high-risk surgical patients with biopsy-proven stage I NSCLC. PET/CT imaging was...

Full description

Bibliographic Details
Main Authors: Chen, Viola J., Oermann, Eric, Vahdat, Saloomeh, Rabin, Jennifer, Suy, Simeng, Yu, Xia, Collins, Sean P., Subramaniam, Deepa, Banovac, Filip, Anderson, Eric, Collins, Brian T.
Format: Online
Language:English
Published: Frontiers Research Foundation 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356163/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356163/

Similar Items